22 
120 days of enactment of this act. During the 180-day period begin- 
ning on the date of enactment, the regulations shall not be less 
stringent than the recombinant DNA guidelines published in part 
II of the Federal Register for July 7, 1976. The Commission must 
promulgate regulations to implement the license requirements of this 
section within 90 days after the date of the promulgation of final 
regulations. These regulations shall — 
(A) prescribe requirements for laboratory safety techniques 
and requirements for monitoring to be followed by workers 
engaged in recombinant DNA activities at licensed facilities ; 
(B) prescribe the requirements for the maintenance of a 
register at a licensed facility which will include the names, 
addresses, and health records of all persons exposed to recom- 
binant DNA in connection with the facility and the require- 
ments for the monitoring by the owner or operator of the facility 
of the health of each such person ; 
(C) will provide requirements for the establishment, func- 
tions and operations of Institutional Biohazards Review Com- 
mittees affiliated with each facility. The composition of the 
members on the committees will be as follows : 
(1) at least one- third of the total members be individuals — 
( a) who are not and have never been professionally en- 
gaged in biological research ; 
(b) who are qualified to serve as members of the gen- 
eral public including persons who by virtue of their 
t raining, experience or background in the fields of medi- 
cine, law, ethics, education, physical, behavioral and so- 
cial sciences, philosophy, humanities, health administra- 
tion, government, or public affairs ; 
(c) who have no financial interest in recombinant DNA 
activities and who are not employees of the owners or 
operators of such facility or of persons who have a finan- 
cial interest; and 
(d) who are residents of a local community which is 
proximate to the facility ; and 
(2) at least another one-third of the total members be 
individuals — • 
(a) who are employees of the owners or operators of 
the facility ; and 
(b) who are qualified through their expertise and train- 
ing to provide a diversity of viewpoints relevant to re- 
combinant DNA activities and technology, biological 
safety and engineering, and biohazard monitoring. 
All recombinant DNA projects to be undertaken by a facility must 
be reviewed and approved by the Institutional Biohazards Review 
Committees in order to assure the adequacy of the containment levels 
(both biological and physical) and the safety of the procedures con- 
templated. The committees must provide public notice to local com- 
munities of all recombinant DNA projects that have been approved. 
The regulations shall include requirements with respect to the re- 
sponsibilities of the owners or operators of the facility to monitor 
compliance of the facility and persons authorized by the license to 
engage in recombinant DNA activities at the facility. 
[ 762 ] 
